Suppression of Long Noncoding RNA SNHG1 Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma via

Qian Chen1, Xiao He1, Bin Li1

  • 1Department of Otolaryngology, The First Affiliated Hospital of Zhejiang Traditional Chinese Medical University, Hangzhou 310006, China.

Abstract

Insights

Long noncoding RNA SNHG1 promotes hypopharyngeal squamous cell carcinoma (HSCC) progression by upregulating PARP6. Silencing SNHG1 inhibits HSCC, suggesting SNHG1/PARP6 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • RNA Biology

Background:

  • Hypopharyngeal squamous cell carcinoma (HSCC) is a challenging malignancy.
  • Understanding the molecular mechanisms driving HSCC is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role and molecular mechanism of long noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) in HSCC development.
  • To explore the SNHG1/PARP6 axis in HSCC pathogenesis.

Main Methods:

  • Utilized the human HSCC cell line FaDu for in vitro experiments.
  • Assessed cell viability, apoptosis, migration, and invasion using CCK-8, flow cytometry, and Transwell assays.
  • Determined protein expression of key molecules including PARP6, XRCC6, β-catenin, E-cadherin, and N-cadherin via Western blotting.
  • Investigated the SNHG1-PARP6 regulatory relationship and in vivo tumorigenicity.

Main Results:

  • SNHG1 suppression reduced HSCC cell viability, migration, and invasion while promoting apoptosis.
  • PARP6 was identified as a target of SNHG1 and was upregulated by SNHG1 knockdown.
  • The SNHG1/PARP6 axis significantly inhibited HSCC cell proliferation, migration, invasion, and in vivo tumorigenicity.
  • SNHG1 suppression or PARP6 overexpression altered the expression of EMT markers, increasing E-cadherin and decreasing N-cadherin, β-catenin, and XRCC6.

Conclusions:

  • SNHG1 silencing inhibits HSCC progression by upregulating PARP6.
  • The XRCC6/β-catenin/EMT pathway may mediate the downstream effects of the SNHG1/PARP6 axis in HSCC.
  • The SNHG1/PARP6 axis represents a promising therapeutic target for HSCC treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K